M&A / Deals UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies PharmaTimesPartnership builds on existing collaboration and adds two new UCBnominated projectsOncologyRead full story pharminent May 7, 2026 (Last updated: May 8, 2026) PharmaTimes Partnership builds on existing collaboration and adds two new UCBnominated projects Oncology Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturingNext: Roche buys AI-powered diagnostics player PathAI Related Stories M&A / Deals Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar pharminent July 10, 2026 M&A / Deals GSK ends dementia alliance with Alector after setbacks pharminent July 9, 2026 M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals pharminent July 8, 2026
